3308907104VENDAS055124852014-09-19133045571121132.2.2633781055002006FUNDACAO OSWALDO CRUZ - INCQSINSTITUTO NACIONAL DE CONTROLE DE QUALIDADE EM SAUDEAV.BRASIL4365MANGUINHOS3304557Rio de JaneiroRJ210403601058BRASIL2138655107770364900002123800373663650000190RANBAXY FARMACEUTICA LTDAAVENIDA EUGENIO BORGES1060ARSENAL3304904Sao GoncaloRJ247510001058BRASIL21354263018539675720056NIMESULIDA293500945101FRASCO1.0000340.0000000000340.00FRASCO1.0000340.00000000001040340.0090707190CLORIDRATO DE FEXOFENADINA293391395101FRASCO1.0000340.0000000000340.00FRASCO1.0000340.00000000001040340.00907070.000.000.000.00680.000.000.000.000.000.000.000.000.00680.000Imunidade nas Operações de ICMS,conforme parágrafo 2 do Inciso IV art.150 da CF/88. O arquivo XML da Nfe está disponível no site www.incqs.fiocruz.br em Produtos e Serviços - Notas Fiscais.LN1X890/Pq2SE62k2xHgAvjwkAI=GAc92anVINSvfjeFL9rndvhzpSvumWhYN0jCKg5lYYKqCL+XW4qTLgexWJa2AcjOgI3cbLG/8ohn
vHznHFjh7U5nHDaX7Oh2paeiXl4CmASoVxvnJjHCawp9WK7scTUfOaVpy5YPxJ7ZN7jmz9o9sVNV
iiEo1RcGwbHsg7F1g9/Gnn+xLzFufMRtlC3YZELnLgbb8OvltaK/D7iGTtHcpiKbn+Vp4FAoonzw
iXN14p/uboJ0uNA9A17wb2OwouQVnAtc7bO+H4Utbw6JN06MdzzRzVm9OuE02JmndKw7RepfuOCI
8+m4sUYqrcbb7xPWYmhxQz9m9+FV2BgX2Z4QlQ==MIIHoTCCBYmgAwIBAgIQMjAxMzExMjUxMzUzNDE4NzANBgkqhkiG9w0BAQsFADCBijELMAkGA1UE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1SVRS20140825154650331409337810550020065500100000248510890710422014-09-23T14:39:46333140126911130LN1X890/Pq2SE62k2xHgAvjwkAI=100Autorizado o uso da NF-e